Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy

Immunopharmacology

Volumn 40, Issue 3, 1998, Pages 231-240

  Hryhorenko, Eric A ^a   Oseroff, Allan R ^a   Morgan, Janet ^a   Rittenhouse Diakun, Kate ^b,c  

^a Roswell Cancer Institute   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Aminolevulinic acid (ALA); Antigen presenting cells; Dendritic cells; Human; Immunomodulation; Mixed lymphocyte reaction (MLR); Photodynamic therapy (PDT)

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANTIGEN SPECIFICITY; ARTICLE; ASSAY; CONTROLLED STUDY; DENDRITIC CELL; DRUG ACCUMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MIXED LYMPHOCYTE REACTION; MONOCYTE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; DENDRITIC CELLS; HLA-D ANTIGENS; HUMANS; LYMPHOCYTES; MACROPHAGES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS;

EID: 0031784787     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00047-2     Document Type: Article

References (30)

1. Bodel P.T., Nichols B.A., Bainton D.F. Appearance of peroxidase reactivity within the rough endoplasmic reticulum of blood monocytes after surface adherence. J. Exp. Med. 145:1977;264-274.
2. Chowdhary R.K., Ratkay L.G., Neyndorff H.C., Richter A., Obochi M., Waterfield J.D., Levy J.G. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 72(2):1994;255-263.
3. Grunner S., Volk H.D., Noack F., Meffert H., Baehr R.V. Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment. Tissue Antigens. 27:1986;147-154.
4. Hammerstrom J. Human macrophage differentiation in vivo and in vitro. Acta. Pathol. Microbiol. Scand. Sect. C. 87:1979;113-120.
5. Hryhorenko E.A., Rittenhouse-Diakun K., Harvey N., Morgan J., Stewart C.C., Oseroff A.R. Analysis and characterization of protoporphyrin IX accumulation in activated peripheral blood lymphocytes by four color flow cytometry. Photochem. Photobiol. 67(5):1998;565-572.
6. Korbelik M., Krosl G. Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer. 73:1996;506-513.
7. Korbelik M., Krosl G., Krosl J., Dougherty G.J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Research. 56:1996;5647-5652.
8. Krutmann J., Athar M., Mendel D.B., Khan I.U., Guyre P.M., Mukhtar H., Elmets C.A. Inhibition of the high affinity Fc receptor (FcγRI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J. Biol. Chem. 264(19):1989;11407-11413.
9. Leong S., Chan A.H., Levy J.G., Hunt D.W.C. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem. Photobiol. 64(5):1996;751-757.
10. Mookerjee B.K., Pauly J.L. Mitogenic effect of interleukin-2 on unstimulated human T cells: an editorial review. J. Clin. Lab. Anal. 4:1990;138-149.
11. Newman S.L., Musson R.A., Henson P.M. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J. Immunol. 125(5):1980;2236-2244.
12. North J., Neyndorff H., Levy J.G. Photosensitizers as virucidal agents. J. Photochem. Photobiol. B: Biol. 17:1993;99-108.
13. Obochi M.O., Ratkay L.G., Levy J.G. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Transplantation. 63(6):1997;810-817.
14. Paul, W.E., 1993. Fundamental Immunology, 3rd edn. Raven Press, New York, NY.
15. Qin B., Selman S.H., Payne K.M., Keck R.W., Metzger D.W. Enhanced skin allograft survival after photodynamic therapy. Transplantation. 56(6):1993;1481-1486.
16. Ratkay L.G., Chowdhary R.K., Neyndorff H.C., Tonzetich J., Waterfield J.D., Levy J.G. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MLR-lpr mice. Clin. Exp. Immunol. 95:1994;373-377.
17. Rittenhouse-Diakun K., van Leengoed H.J., Hryhorenko E., Paszkiewicz G., Whitaker J.E., Oseroff A. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor 5-aminolevulinic acid (ALA). Photochem. Photobiol. 61:1995;523-528.
18. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:1994;83-93.
19. Stewart C.C., Stewart S.J. Cell preparation for the identification of leukocytes. Methods In Cell Biology. 41:1994;39-60.
20. Stewart C.C., Stewart S.J. Multiparameter analysis of leukocytes by flow cytometry. Methods In Cell Biology. 41:1994;61-79.
21. Strickland F.M., Kripke M.L. Immune response associated with nonmelanoma skin cancer. Clinics in Plastic Surgery. 24(4):1997;637-647.
22. Thomas R., Lipsky P.E. Dendritic cells: origin and differentiation. Stem Cells. 14:1996;196-206.
23. Ullrich S.E. Modulation of immunity by ultraviolet radiation: key effects on antigen presentation. J. Invest. Dermatol. 105:1995;30s-36s.
24. Van Voorhis W., Hair L.S., Steinman R.M., Kaplan G. Human dendritic cells. J. Exp. Med. 155:1982;1172-1187.
25. Wright-Browne V., McClain K.L., Ordonez N. Physiology and pathophysiology of dendritic cells. Human Pathology. 28(5):1997;563-579.
26. Yamamoto N., Homma S., Sery T.W., Donoso L.A., Hoober J.K. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. Eur. J. Cancer. 27(4):1991;467-471.
27. Zhou L.J., Schwarting R., Smith H.M., Tedder T.F. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149(2):1992;735-742.
28. Zhou L.J., Tedder T.F. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood. 86(9):1995;3295-3301.
29. Zhou L.J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154(8):1995;3821-3835.
30. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2588-2592.